[
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
    "summary": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1101c9888a0762ff0bfec6794d4f69af4f1378db9dfc89001f8333d3153d57de",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761237180,
      "headline": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
      "id": 137226250,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1101c9888a0762ff0bfec6794d4f69af4f1378db9dfc89001f8333d3153d57de"
    }
  },
  {
    "ts": null,
    "headline": "United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall",
    "summary": "The United States Chronic Obstructive Pulmonary Disease (COPD) Market is projected to grow from US$ 3.97 billion in 2024 to US$ 4.92 billion by 2033, at a CAGR of 2.42%. Factors driving this growth include an aging population, heightened smoking rates, and environmental influences. The demand for innovative inhalers, biologics, and rehabilitation programs is rising. Key segments include chronic bronchitis and emphysema, with treatment options spanning drugs, oxygen therapy, and surgery. States l",
    "url": "https://finnhub.io/api/news?id=c71cd6e181f0deeeb69881f06ea43c4f632fd7742a51c44af85236f556c4c0bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761212280,
      "headline": "United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall",
      "id": 137197962,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The United States Chronic Obstructive Pulmonary Disease (COPD) Market is projected to grow from US$ 3.97 billion in 2024 to US$ 4.92 billion by 2033, at a CAGR of 2.42%. Factors driving this growth include an aging population, heightened smoking rates, and environmental influences. The demand for innovative inhalers, biologics, and rehabilitation programs is rising. Key segments include chronic bronchitis and emphysema, with treatment options spanning drugs, oxygen therapy, and surgery. States l",
      "url": "https://finnhub.io/api/news?id=c71cd6e181f0deeeb69881f06ea43c4f632fd7742a51c44af85236f556c4c0bc"
    }
  },
  {
    "ts": null,
    "headline": "GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex",
    "summary": "The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21% from 2025 to 2033. This growth is driven by an increase in chronic diseases, surgical procedures, and advanced healthcare infrastructure across GCC countries. The demand for minimally invasive treatments and the aging population further bolster market expansion. Key sectors such as cardiovascular, microcatheters, and intermittent catheters are witnessing significant grow",
    "url": "https://finnhub.io/api/news?id=fce5d1ea8f0bddc4ec9de6a99102bb87c65387bd0a9313713100f27104bcde46",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761210540,
      "headline": "GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex",
      "id": 137197767,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21% from 2025 to 2033. This growth is driven by an increase in chronic diseases, surgical procedures, and advanced healthcare infrastructure across GCC countries. The demand for minimally invasive treatments and the aging population further bolster market expansion. Key sectors such as cardiovascular, microcatheters, and intermittent catheters are witnessing significant grow",
      "url": "https://finnhub.io/api/news?id=fce5d1ea8f0bddc4ec9de6a99102bb87c65387bd0a9313713100f27104bcde46"
    }
  },
  {
    "ts": null,
    "headline": "1 Safe-and-Steady Stock with Exciting Potential and 2 We Question",
    "summary": "Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.",
    "url": "https://finnhub.io/api/news?id=2ac57718342e50c43d9ee908b6a8d9a2484d4e0c3751364495936dec2237e460",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761194268,
      "headline": "1 Safe-and-Steady Stock with Exciting Potential and 2 We Question",
      "id": 137197964,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.",
      "url": "https://finnhub.io/api/news?id=2ac57718342e50c43d9ee908b6a8d9a2484d4e0c3751364495936dec2237e460"
    }
  }
]